SEC Form 4 · accession 0001225208-16-040697
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Flynn
Officer — Sr VP & Chief Commercial Offic
Period of report
Oct 21, 2016
Accepted (ET)
Oct 24, 2016 · 10:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 21, 2016 | A | 10 | $71.68 | A | 1,179 | I | Non-Qualified Deferred Compensation Plan |
| Common StockF1 | holding | — | — | — | 13,580 | D | ||
| Common StockF1 | holding | — | — | — | 251 | I | By Savings Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.